|Item#||Name||Size & Form||Brand||Price||Actions|
NOW® Celadrin® Lotion can help support joint and cartilage response to physical activity, exercise and postural stability. As evidenced by a 2005 University led, placebo controlled study, topical Celadrin® (7.5%) was shown to deliver esterified fatty acid carbons and other active ingredients capable of significantly reducing joint discomfort while increasing joint function and balance. (J Strength Cond Res. 2005 Feb; 19(1): 115-21).†
LIKELY USERS: People lacking flexibility or mobility; People wanting temporary control of aches and pains; People wanting to reduce pro-inflammatory body chemicals
KEY INGREDIENT(S): Celadrin 500 mg.
MAIN PRODUCT FEATURES: CELADRIN is an all-natural proprietary matrix of esterified (cetylated) fatty acid carbons (EFAC) derived from tallow of USA-raised cattle. This product is developed through a proprietary process of esterifying oil & has been clinically tested. Celadrin promotes joint health by improving flexibility, painmanagement and mobility. The myristoleic acids and the cetylated forms may alter the 5-LOXenzyme and change the leukotriene production, inhibiting inflammatory compounds.
Celadrin may offer some noticeable benefits faster than other substances,like glucosamine and chondroitin. It is not a substitute for these important nutrients, though.
OTHER IMPORTANT ISSUES: MSM has synergistic abilities to reduce certain substances in the body which may affect inflammation.
AMOUNT and HOW TO USE: Three capsules a day, preferably with meals.
SYNERGISTS: Glucosamine, Chondroitin, MSM, Joint Support Products, Manganese, Vitamin C, other Antioxidants
CAUTIONS: Please notify your physician about your supplement use if you are using any drugs!
1. J Rheumatol. 2002 Aug;29(8):1708-12. Cetylated fatty acids improve knee function in patients with osteoarthritis. Hesslink R Jr, Armstrong D 3rd, Nagendran MV, Sreevatsan S, Barathur R.
2. Anticancer Res. 2003 Jan-Feb;23(1A):453-8. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Ebisuzaki K.
3. J Altern Complement Med. 2002 Apr;8(2):167-73. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN. (allergy related inflammation
*Statements on this site have not been evaluated by the Food and Drug Administration. Products on this site are not intended to diagnose, treat, cure, or prevent any disease.
Prices are subject to change at anytime and without notice. The majority of the product information has been reprinted from the manufacturer.